Senior Regulatory Affairs Executive
5 Years of Experience Pharmaceutical research and medical device regulatory
Introduction
When a medical device manufacturer submits an FDA 510(k), the first stage is an acceptance review. Before beginning the substantive technical evaluation, the FDA checks whether the submission contains the required information and is sufficiently organized for review.
Missing documents, incomplete sections or inconsistencies can prevent a submission from moving forward. In such cases, the FDA may issue a Refuse to Accept (RTA) notification, placing the submission on hold until the identified deficiencies are addressed.
Manufacturers should therefore understand the acceptance review requirements before submitting their 510(k). A properly prepared file makes it easier for the reviewer to locate the required information and reduces the risk of avoidable administrative delays.
What Is FDA 510(k) Acceptance Review?
The FDA 510(k) acceptance review is the initial screening stage in which the agency determines whether a premarket notification meets the minimum requirements for substantive review.
At this stage, the FDA primarily checks submission completeness, required administrative information and the presence of applicable supporting documentation. The reviewer does not conduct the full scientific and technical assessment of device safety and performance during this screening.
The review follows the applicable FDA acceptance checklist. The requirements depend on the type of 510(k) submission, including Traditional, Special and Abbreviated submissions.
In practical terms, manufacturers should ensure that:
All required submission documents are included.
Information is consistent across the different sections.
Supporting evidence is clearly identified and accessible.
Submission files follow an appropriate structure.
Applicable forms, declarations and payment requirements are addressed.
Even a relatively small documentation gap can affect the acceptance outcome.
FDA 510(k) RTA Checklist: Key Elements Reviewed
The FDA uses submission-type-specific acceptance checklists to assess whether a 510(k) contains the information required to proceed to substantive review.
The following areas are important when preparing a submission.
1. Administrative Information
The administrative section contains the basic information required to identify and process the submission.
Manufacturers should review:
Cover letter and submission details.
Required FDA forms and declarations.
Applicable user fee payment confirmation.
Submission identification and contact information.
Required administrative attachments.
Incomplete or inconsistent administrative information can create problems before the technical review begins.
2. Device Description
The device description should explain what the device is, how it works and how it will be used.
It should cover:
Device design and configuration.
Intended use and indications for use.
Main technological characteristics.
Relevant components and operating principles.
Applicable accessories or software components, where relevant.
The description should remain consistent throughout the submission. Differences between the device description, labeling and supporting documentation can create questions during review.
3. Substantial Equivalence and Predicate Device Comparison
A 510(k) submission must identify an appropriate predicate device and establish substantial equivalence.
The documentation should include:
Identification of the selected predicate device.
Comparison of intended uses.
Comparison of technological characteristics.
Relevant performance characteristics.
Explanation of similarities and differences.
Scientific justification supporting the substantial equivalence determination.
A comparison table can help reviewers understand the relationship between the proposed device and its predicate. Any differences should be explained and supported by appropriate evidence.
4. Labeling
Labeling information must be consistent with the device’s intended use and the claims made in the submission.
Relevant documents include:
Instructions for use (IFU).
Device labels.
Warnings and precautions.
Contraindications, where applicable.
Relevant indications and usage information.
Inconsistencies between labeling and the intended use described elsewhere in the submission can lead to questions or deficiencies.
5. Performance Data
The submission should contain the applicable performance information supporting the substantial equivalence argument.
Depending on the device, this may include:
Bench testing results.
Biocompatibility data, where applicable.
Sterilization validation and supporting information, where applicable.
Relevant performance verification and validation results.
Other testing information necessary to support the submission.
The data should be presented clearly and linked to the relevant device characteristics and performance claims.
If a required section is incomplete or unclear, the FDA may identify the deficiency during the acceptance process or raise questions during subsequent review.
Step-by-Step FDA 510(k) Acceptance Review Process
Understanding the review sequence helps manufacturers prepare their submissions and anticipate the next regulatory steps.
Step 1: Submission Receipt
The FDA receives the 510(k) submission and begins the applicable administrative processing.
The agency verifies the required user fee payment and the validity of the submitted eSTAR or eCopy. Once these requirements are satisfied, an acknowledgment letter identifies the receipt date and assigned 510(k) number.
Step 2: Administrative Screening
The submission is routed to the appropriate FDA office and assigned to a lead reviewer.
Basic submission information, payment status and the applicable submission format are checked.
Step 3: Checklist-Based Acceptance Evaluation
The reviewer evaluates the submission against the relevant acceptance checklist.
The review focuses on whether the required information is present and whether the submission meets the minimum threshold for substantive review.
Step 4: Acceptance Review Outcome
The FDA communicates the acceptance review result.
There are three possible outcomes:
Accepted for substantive review: The submission moves to the next review stage.
Refuse to Accept (RTA): The submission is placed on hold until the identified deficiencies are addressed.
Acceptance review not completed within 15 calendar days: The submission may proceed to substantive review, with the FDA notifying the submitter of its status.
For an RTA hold, the submitter generally has 180 calendar days to address the deficiencies identified by the FDA. Failure to resolve them within that period can result in withdrawal and deletion of the submission.
Important: The FDA’s process distinguishes between eCopy and eSTAR submissions. The traditional RTA acceptance checklist process applies to eCopy submissions. FDA indicates that eSTAR submissions are not anticipated to undergo the same RTA process because the template is intended to support complete submissions, although technical screening still applies.
Common FDA 510(k) Acceptance Review Mistakes That Cause Delays
Many acceptance-stage problems arise from documentation gaps that could have been identified during an internal review.
Incomplete Device Description
The device description may omit relevant details about design, functionality, intended use or technological characteristics.
If reviewers cannot clearly understand the proposed device from the documentation, additional clarification may be necessary.
Weak Predicate Device Comparison
An unsuitable predicate selection or an inadequately explained comparison can weaken the substantial equivalence justification.
Manufacturers should explain the differences between the proposed device and predicate and provide the relevant supporting evidence.
Inconsistent Labeling
Labeling may contain incomplete information or statements that do not match the intended use described elsewhere in the submission.
The IFU, device labels and indications for use should be reviewed together before submission.
Poor Document Organization
Files may be difficult to navigate because of inconsistent naming, unclear section references or missing attachments.
A logical submission structure and an accurate table of contents help reviewers locate the required information.
Gaps in Supporting Data
Testing information may be incomplete, insufficiently explained or disconnected from the relevant device requirements.
Performance documentation should clearly identify the test, its purpose, the applicable device configuration and the results.
These problems can create avoidable review questions and, depending on the deficiency, may affect acceptance.
How to Prepare a Complete FDA 510(k) Submission
A structured preparation process helps manufacturers identify documentation gaps before the submission reaches the FDA.
Follow the Applicable FDA Acceptance Checklist
Use the acceptance checklist relevant to the submission type during preparation.
Review each applicable item and identify where the corresponding information appears in the submission. The FDA recommends that submitters use the checklist to help establish completeness.
Maintain Consistency Across Documents
Compare the device description, intended use, labeling, predicate comparison and performance documentation.
Product names, configurations, indications and technical specifications should remain consistent wherever they appear.
Organize Submission Files Properly
Use clear section numbering, file names and cross-references.
Prepare a table of contents that identifies the required information and its location. An organized file makes it easier to locate supporting evidence.
Conduct an Internal Review
An internal review should take place before submission.
Regulatory and technical reviewers can check whether the required documents are present, whether the evidence supports the claims and whether inconsistencies remain.
Seek Expert Regulatory Input When Needed
Experienced regulatory professionals can review submission readiness, identify missing information and assess whether the documentation supports the proposed regulatory strategy.
Early review can help manufacturers address problems before submission.
Preparing an FDA 510(k) submission?
Explore Operon Strategist’s US FDA 510(k) regulatory consulting services for support with submission strategy, predicate selection and technical documentation.
Acceptance Review vs. Substantive Review
The acceptance review and substantive review are separate stages of the FDA 510(k) process. Understanding their different objectives helps manufacturers prepare the right documentation at each stage.
| Aspect | Acceptance Review | Substantive Review |
|---|---|---|
| Focus | Submission completeness and minimum acceptability | Scientific and technical evaluation |
| Objective | Determine whether the submission can proceed | Evaluate substantial equivalence |
| Main assessment | Required information and applicable checklist elements | Device characteristics, performance and supporting evidence |
| Outcome | Acceptance, RTA hold or applicable review-status notification | Substantial equivalence determination or further information requests |
Acceptance review establishes whether the submission is ready to enter substantive review. The subsequent assessment examines whether the device is substantially equivalent to the identified predicate.
FDA 510(k) Acceptance Review Timeline
The FDA generally completes the acceptance review within 15 calendar days of receipt of the submission.
During this period, the agency determines whether the 510(k) meets the applicable minimum acceptance requirements.
If the submission is not accepted, the FDA identifies the deficiencies in its RTA notification. The submission is then placed on hold while the manufacturer prepares and submits the required corrections.
The FDA generally allows 180 calendar days to resolve the deficiencies identified in an RTA hold. If the issues remain unresolved after that period, the submission may be considered withdrawn and deleted from the review system.
For manufacturers, the practical implication is straightforward: submission readiness should be assessed before the file is sent to the FDA. Correcting incomplete documentation after submission can extend the overall process.
Practical Insight from Industry Experience
In many submissions, problems arise from small but important documentation gaps.
For example, a device description may be included but fail to explain an important technical characteristic. A testing report may be present, but its results may not clearly support the claims made elsewhere in the submission. In other cases, the labeling and intended-use statements may contain differences that have not been addressed.
These gaps make it harder to assess the submission and may lead to requests for clarification or an RTA hold, depending on the nature of the deficiency.
Manufacturers can reduce these risks by checking the documents together, instead of reviewing each section in isolation. A consistent submission gives reviewers a clearer picture of the device and the evidence supporting its substantial equivalence.
Why Structured FDA 510(k) Submission Preparation Matters
The acceptance review is an important checkpoint in the regulatory submission process.
A complete file, accurate cross-references and consistent technical information make it easier for the FDA to locate and assess the required material. By reviewing the applicable checklist before submission, manufacturers can identify missing information and address documentation problems earlier.
The quality of preparation at this stage also affects how efficiently the submission moves into substantive review.
Role of Operon Strategist in FDA 510(k) Acceptance Review
Preparing an FDA 510(k) submission requires an understanding of the regulatory pathway, device requirements and supporting technical documentation.
Operon Strategist, through its Operon ElevatePlus services, supports medical device manufacturers with FDA 510(k) preparation and regulatory consulting.
Its verified service portfolio includes:
FDA 510(k) regulatory strategy: Device classification and regulatory pathway assessment.
Predicate device identification: Research and evaluation of potential predicate devices.
Substantial equivalence documentation: Preparation of comparisons and supporting justification.
Technical documentation: Development of device descriptions, labeling and performance documentation.
FDA submission support: Submission preparation, status monitoring and communication support.
QMS alignment: Support for FDA quality-system requirements and ISO 13485-aligned quality systems.
Post-submission support: Assistance with FDA questions, deficiencies and additional information requests.
The company also provides Quality Management System (QMS) consulting, including QMS gap assessments, documentation development, CAPA planning and audit-readiness support.
These services can help manufacturers review submission documentation before filing and address gaps that could affect regulatory progress.
Why This Support Matters
A submission may contain extensive technical information and still have gaps in how that information is presented or referenced.
A structured regulatory review helps identify inconsistencies between device descriptions, labeling, predicate comparisons and supporting test data. It also helps manufacturers check whether the submission addresses the applicable acceptance checklist requirements.
For companies preparing an FDA 510(k), early regulatory input can help improve documentation readiness and reduce avoidable submission problems.
Need a regulatory review before your FDA 510(k) submission?
Contact Operon Strategist to discuss FDA 510(k) preparation, predicate comparison and technical documentation support.
FAQ
What is the FDA 510(k) Acceptance Review?
The FDA 510(k) acceptance review is the initial screening stage in which the agency checks whether a premarket notification meets the minimum requirements for substantive review. It focuses on submission completeness and applicable administrative and documentation requirements
What is the FDA 510(k) Refuse to Accept (RTA) checklist?
The RTA checklist is used by the FDA to assess whether a 510(k) submission meets the minimum threshold of acceptability. The FDA provides different checklists for Traditional, Special and Abbreviated 510(k) submissions.
What are the common reasons for FDA 510(k) acceptance delays?
Common issues include incomplete administrative information, unclear device descriptions, weak predicate comparisons, inconsistent labeling, poorly organized files and missing or insufficient supporting documentation.
How can manufacturers prevent delays during the FDA 510(k) acceptance review?
Manufacturers should use the applicable FDA acceptance checklist, maintain consistency across documents, organize files clearly and conduct an internal regulatory review before submission. Expert regulatory input can also help identify gaps.
How long does the FDA 510(k) acceptance review take?
The FDA generally completes the acceptance review within 15 calendar days of receiving the submission. If the submission receives an RTA notification, the manufacturer generally has 180 calendar days to resolve the identified deficiencies before the submission may be withdrawn and deleted.
Dr. Ankita N. Yawalkar
Senior Regulatory Affairs Executive | 5 Years of Experience
Pharmaceutical research and medical device regulatory professional specializing in EU MDR technical documentation, US FDA 510(k) submissions, clinical evaluation, and risk management. Her expertise includes regulatory documentation for medical devices, Software as a Medical Device (SaMD), and drug–device combination products across US and EU markets.
Research and Publications: RA1 | RA2 | RA3 | RA4 | FDA Regulatory Dashboard


